The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 25, 2023
Filed:
Jul. 03, 2019
Applicant:
Memorial Sloan Kettering Cancer Center, New York, NY (US);
Inventors:
Marcus Ruscetti, New York, NY (US);
John P. Morris, IV, New York, NY (US);
Scott Lowe, New York, NY (US);
Assignee:
Memorial Sloan Kettering Cancer Center, New York, NY (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/535 (2006.01); A61P 35/00 (2006.01); A61K 31/145 (2006.01); A61K 31/18 (2006.01); A61K 31/185 (2006.01); A61K 31/4184 (2006.01); A61K 31/44 (2006.01); A61K 31/4412 (2006.01); A61K 31/4523 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01);
U.S. Cl.
CPC ...
A61K 31/535 (2013.01); A61K 31/145 (2013.01); A61K 31/18 (2013.01); A61K 31/185 (2013.01); A61K 31/4184 (2013.01); A61K 31/44 (2013.01); A61K 31/4412 (2013.01); A61K 31/4523 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61P 35/00 (2018.01);
Abstract
The present technology provides methods for treating pancreatic cancer using a MEK inhibitor and a CDK4/6 inhibitor. Also disclosed herein are methods for increasing patient responsiveness to chemotherapeutic and/or immunotherapeutic regimes for pancreatic cancer. Kits for use in practicing the methods are also provided.